t71684_8k.htm

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 5, 2011

(Exact Name of Registrant as Specified in its Charter)

New York		000-04217		11-1720520
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

4 Tri Harbor Court, Port Washington, NY 11050

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (516) 627-6000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13-e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

	On October 5, 2011, Vincent G. Miata, President and Chief Operating Officer of Aceto Corporation (“Aceto” or the “Company”), notified the Company of his decision to resign from the Company’s Board of Directors (the “Board”) effective immediately, and the Board met and accepted his resignation. In addition, on October 5, 2011, Mr. Miata and the Company mutually agreed that he would resign from his positions as President and Chief Operating Officer of the Company effective as of October 7, 2011. There were no disagreements between the Company and Mr. Miata on any matter relating to the Company’s operations, policies or practices. A separation agreement specifying the final terms of Mr. Miata’s departure from the Company is currently being negotiated. On October 5, 2011, the Board appointed Salvatore Guccione, age 48, President and Chief Operating Officer of Aceto effective as of December 1, 2011. Mr. Guccione will continue to serve in his role on the Board and stand for re-election at the annual meeting of shareholders on December 8, 2011. Mr. Guccione was formerly an Operating Partner at Arsenal Capital Partners, a private equity investment firm based in New York. Prior to that, Mr. Guccione was the Chief Executive Officer and the Chief Financial Officer of WIL Research Laboratories from 2006 to 2009 and the Chief Financial Officer of International Specialty Products from 2004 to 2005. In addition, Mr. Guccione held various positions at Cambrex Corporation from 1995 to 2004, including Executive Vice President, Strategy and Chief Financial Officer. From 1987 to 1995, Mr. Guccione held various positions at International Specialty Products, including Vice President and General Manager, Personal Care and Director, Corporate Development. Mr. Guccione holds a Bachelor degree in Chemical Engineering from Lehigh University and an MBA in Finance from New York University's Stern School of Business. Mr. Guccione joined Aceto’s Board in May 2011. Mr. Guccione serves on the Board of Royal Adhesive & Sealants Holdings and on the Board of DG3 Holdings. In connection with his appointment, the Company agreed to provide Mr. Guccione with: (i) an annual base salary of $425,000, (ii) a target annual bonus of 40% of base salary, (iii) special equity awards consisting of 62,500 stock options and 25,000 shares of restricted stock (which vest ratably over three years), (iv) fiscal 2012 equity awards consisting of 13,000 stock options, 7,500 shares of restricted stock and 7,500 performance-vested restricted stock units (also subject to vesting over three years, except for the performance-vested restricted stock units, which vest (if at all) after three years), and (v) an automobile leased by the Company in accordance with Company policy. In addition, if Mr. Guccione’s employment is terminated by the Company without cause, the Company will provide him with fifteen months’ base salary as severance, subject to his execution of a release. Mr. Guccione also agreed to enter into the Company’s standard confidentiality and non-disclosure agreement.

There are no family relationships between Mr. Guccione and any other executive officers or directors of Aceto. Mr. Guccione was not selected as President and Chief Operating Officer pursuant to any arrangement or understanding with any other person, and does not have any reportable transactions under Item 404(a) of Regulation S-K.

The press release related to this matter is furnished as an exhibit to this report.

Item 9.01

Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Description

99.1	Press Release dated October 6, 2011

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ACETO CORPORATION



Date: October 6, 2011	By: /s/ Albert L. Eilender
	Albert L. Eilender
	Chairman of the Board and
	Chief Executive Officer

	Aceto Corporation 4 Tri Harbor Court Port Washington, New York 11050

“Sourcing and Supplying Quality Products Worldwide”	NEWS RELEASE

FOR IMMEDIATE RELEASE

Aceto Corporation Announces Salvatore Guccione Named

President and COO

PORT WASHINGTON, NY – October 6, 2011 – Aceto Corporation (NASDAQ:ACET), a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and agricultural protection products, today announced that Salvatore Guccione has accepted the position of President and Chief Operating Officer effective on or before December 1, 2011.

Albert L. Eilender, Chairman and CEO of Aceto reported “After 33 years of loyal dedicated service with Aceto, Vince Miata has tendered his resignation. His last day with the Company will be October 7, 2011. Please join me in wishing Vince success in whatever his endeavors will entail.”

Commenting on Mr. Guccione, Mr. Eilender stated “We believe that the experience and talents of Sal Guccione, our new President and Chief Operating Officer, will help to greatly enhance shareholder value. Sal and Ron Gold our President and Chief Operating Officer of Rising Pharmaceuticals will both report to me. Sal, who joined our Board in May 2011, has significant strategic, operational and business acumen and will be a valuable asset as we navigate through the competitive environment in which we operate. He has nearly 25 years of experience in the specialty chemicals and healthcare related industries and has held senior level management positions as a CEO, and CFO with three U.S. based international organizations. Sal has been instrumental in the development and management of several international specialty chemical and pharmaceutical/FDA regulated businesses in active pharmaceutical ingredients, pharmaceutical research services and biotechnology products/services.”

Sal will also continue to serve on the company’s Board of Directors and will stand for reelection at our December 8 Annual meeting.

Most recently Mr. Guccione has served as an Operating Partner at Arsenal Capital Partners, a private equity investment firm based in New York. As Operating Partner, he has been responsible for setting strategy for, and executing upon, strategic acquisitions in the specialty chemicals and pharmaceutical product or service sectors. Mr. Guccione holds a Bachelor degree in Chemical Engineering from Lehigh University and an MBA in Finance from New York University’s Stern School of Business.

ABOUT ACETO

Aceto Corporation, incorporated in 1947, is a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and agricultural protection products. With business operations in ten countries, Aceto distributes over 1000 chemical compounds used either as principal raw materials or as finished products in the pharmaceutical, agricultural, surface coating/ink and general chemical consuming industries. Aceto’s global operations, including a staff of 26 in Shanghai and 12 in India are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities. (ACET-F)

This news release contains forward-looking statements as that term is defined in the federal securities laws. The events described in forward-looking statements contained in this news release may not occur. Generally, these statements relate to our business plans or strategies, projected or anticipated benefits or other consequences of Aceto’s plans or strategies, financing plans, projected or anticipated benefits from acquisitions that Aceto may make, or projections involving anticipated revenues, earnings or other aspects of Aceto’s operating results or financial position, and the outcome of any contingencies. Any such forward-looking statements are based on current expectations, estimates and projections of management. Aceto intends for these forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "project," "plan," "intend," "estimate," and "continue," and their opposites and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained in this press release include, but are not limited to, statements regarding the Company’s strategic initiatives including selling finished dosage form generic drugs, and statements regarding the prospects for long-term growth. Aceto cautions you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond Aceto’s control, which may influence the accuracy of the statements and the projections upon which the statements are based. Factors that could cause actual results to differ materially from those set forth or implied by any forward-looking statement include, but are not limited to, risks and uncertainties discussed in Aceto’s reports filed with the Securities and Exchange Commission, including, but not limited to, Aceto’s Annual Report or Form 10-K for the fiscal year ended June 30, 2011 and other filings. Copies of these filings are available at www.sec.gov.

Any one or more of these uncertainties, risks and other influences could materially affect Aceto’s results of operations and whether forward-looking statements made by Aceto ultimately prove to be accurate. Aceto’s actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. Aceto undertakes no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

For information contact:

Theodore Ayvas

Director of Corporate Communications

& Investor Relations

Aceto Corporation

(516) 627-6000